BERTopic results plotkins vaccines

Topic 0
  Auto Label:        Vaccines
  Descriptive Label: Vaccines – Adjuvants
  Keywords:          live, vaccines, cmi, immunity, adjuvants, mucosal, safe, diseases, attenuated, vaccine adjuvants
  Summary:           Adjuvants are substances that are added to vaccine antigens to enhance and modulate the immunogenicity of the antigen. Currently 10 adjuvants are approved for use in vaccines as adjuants in licensed and investigational vaccines.

Topic 1
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Immunol
  Keywords:          , , , , , , , , , 
  Summary:           Vaccine. Clin Vaccine Immunol

Topic 2
  Auto Label:        Antigens
  Descriptive Label: Antigens
  Keywords:          aluminum, salts, aluminum salts, aluminum containing, freezing, hydroxide, committee, containing, containing vaccines, aluminum hydroxide
  Summary:           Alum was used there- after as an adjuvant for numerous human vaccines. Other aluminum salts, in the form of aluminum oxyhy- droxide or hydroxyphosphate, are the most widely used adju- vants.

Topic 3
  Auto Label:        Hemocyanin
  Descriptive Label: Hemocyanin
  Keywords:          lomavirus, hpv)-16/18, analysis, agonist vaccine, papil-, as04 adjuvanted, hpv)-16/18 as04, lomavirus hpv)-16/18, papil- lomavirus, human papil-
  Summary:           In 2009, the molecule mono- phosphoryl lipid (MPL) A was the first new adjuvant in a vaccine (Cervarix vaccine against human papillomavirus)

Topic 4
  Auto Label:        Influenza
  Descriptive Label: Influenza – Freund
  Keywords:          oil, water oil, freund, water, emulsion, oil emulsion, freund adjuvant, mineral, mineral oil, squalene
  Summary:           In the 1940s, Jules Freund developed a water-in-oil emul- sion, the Freund adjuvant. The latter was briefly used for a commercial influenza vaccine in the United Kingdom in the 1960s.

Topic 5
  Auto Label:        Fluad
  Descriptive Label: Fluad
  Keywords:          seasonal, seasonal influenza, influenza, elderly, mf59, elderly adults, adjuvanted, fluad, mf59 adjuvanted, influenza vaccines
  Summary:           MF59 was approved only in one vaccine, FLUAD, an influenza vaccine for older adults, and licensed in several European countries from 1997 onward. Oil-in-water emulsion adjuvants are highly effective at enhancing immunogenicity and allowing for dose reduction in pandemic influenza vaccines.

Topic 6
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Adjuvants
  Keywords:          safety evaluation, adju- vants, vants, events, safety, adju-, vaccine safety, benefit balance, vaccine related, events reported.128
  Summary:           128 Holding clinical development of a vaccine based on a single adverse event demonstrates the challenges of developing vaccines with novel adjuvants. The risk-to-benefit balance associated with the vaccine being devel- oped will always be the guiding principle.

Topic 7
  Auto Label:        Influenza
  Descriptive Label: Influenza – Antibody
  Keywords:          clade, repertoire, antibody repertoire, diversity affinity, affinity, diversity, antibody, adjuvanted influenza, pandemic, enhance
  Summary:           Oil-in-water adjuvants not only enhance the immune response and allow for dose reduction, but also enhance diversity and affinity of the antibodies induced.63 This qualitative and quan- titative expansion of the antibody repertoire has tremendous relevance for vaccination against pathogens.

Topic 8
  Auto Label:        Malaria
  Descriptive Label: Malaria – Vaccines
  Keywords:          cpg, alhydrogel cpg, alhydrogel, stage, blood, plasmodium, blood stage, phase, induced faster, seroprotection induced
  Summary:           CpG has been evaluated with and without alum for malaria vaccines,104,105 conjugate pneumonia vaccines,106 and hepatitis B vaccines107,108. CpG permits rapid and long-term seroprotection in HIV-infected patients.

Topic 9
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Influenza
  Keywords:          polymer, ethylene, polymers, cationic, properties.142 little, component vaccine, contains polyoxidonium,141, parenteral, polymers includes, class polymers
  Summary:           The influenza vaccine Grippol licensed in Russia contains polyoxidonium. An analogous polymer, poly(carboxylatophenoxy) phosphazene (PCPP) has been widely investigated as an adju- vant for vaccines and has been shown to exert adjuvant activity.

Topic 10
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Virosomes
  Keywords:          virosomes, membrane, licensed, peptides, liposomal membrane, adjuvant carrier, vaccine virosomes, virosomes vaccine, licensed inflexal, sponsor
  Summary:           Several licensed vaccines contain virosomes, which are recon- stituted empty envelopes of influenza viruses. Virosomes have been used for influenza vaccines and as adjuvants for hepatitis A vaccine (licensed in Europe as Epaxal)

Topic 11
  Auto Label:        Hepatitis
  Descriptive Label: Hepatitis
  Keywords:          strains, hpv, clinical trial, clinical, demonstrated acceptable, fendrix vaccine, patients extensive, hpv vaccine, vaccine hemodialyzed, acceptable safety
  Summary:           Vaccine. vaccines (Cervarix [HPV vaccine] and Fendrix [hepatitis B vaccine for hemodialyzed patients]).

Topic 12
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Cpg
  Keywords:          cpg, small, cancer, expert, evaluation efficacy, motifs inducing, b, containing oligonucleotides, pure cpg, cpg containing
  Summary:           CPG has also been used in cancer vaccines, such as non– small-cell lung cancer or melanoma, but as of this writing, with no significantly positive results in humans. CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral- treated HIV-infected adults.

Topic 13
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Narcolepsy
  Keywords:          positive, benefit risk, risk profile, age years, narcolepsy, age, older, risk, adjuvanted vaccine, viral
  Summary:           An increased number of cases of narcolepsy has been reported in children and adolescents vaccinated with an AS03-adjuvanted H1N1 pandemic vaccine in three northern European coun- tries. 2009–2010 pandemic season showed a positive benefit-to-risk profile for the vaccines.

Topic 14
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Influenza – T14
  Keywords:          ferrets, cross, neutralizing antibodies, cross -, induces, neutralizing, responses ferrets, humoral immune, cellular humoral, cellular
  Summary:           A single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protec- tive cellular and humoral immune responses in ferrets. This adju- vant has been reported to allow for dose sparing in the context of influenza vaccines.

Topic 15
  Auto Label:        Vaccines
  Descriptive Label: Vaccines – Adjuvant
  Keywords:          mpl, sparing, dose sparing, pertussis, combination, dose, development noteworthy, vaccines development, immunostimulants described, noteworthy combination
  Summary:           AS01, the combination of liposome, MPL and QS21, will most likely be the next new adjuvant present in a licensed vaccine. AS03 demonstrated potent dose-sparing potential for pan- demic influenza antigens.

Topic 16
  Auto Label:        Dmlt
  Descriptive Label: Dmlt
  Keywords:          dmlt, coli, oral, double, inactivated, tigated adjuvant, inactivated influenza, randomized placebo, placebo, etec vaccine
  Summary:           160 Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxi- genic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants.

Topic 17
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Immune
  Keywords:          flagellin, recombinant, influenza vaccine, tlr-5, response elderly, fusion, immunopotentiation, vax102, fused, nicity recombinant
  Summary:           Vaccine. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagel- lin, with a recombinant hemag

Topic 18
  Auto Label:        Vaccines
  Descriptive Label: Vaccines – Iscom
  Keywords:          relies, vaccines second, matrix, m, future, technology, second, le, success, clinical studies
  Summary:           IsCOM technology-based matrix M adjuvant: success in future vaccines relies on formula-

Topic 19
  Auto Label:        Malaria
  Descriptive Label: Malaria – Vaccine
  Keywords:          rts, rts s, s, date, dren randomized, candidates children, randomized trial, adju- vanted, chil- dren, rts malaria
  Summary:           The malaria vaccine candi- date RTS,S/AS is in phase III clinical trials [in French].


Document-Level Assignments:
Doc 1: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 2: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 3: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 4: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 5: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 0.98694375
Doc 6: Topic 4 (Auto: Influenza; Descriptive: Influenza – Freund), Prob: 1.00000000
Doc 7: Topic 4 (Auto: Influenza; Descriptive: Influenza – Freund), Prob: 1.00000000
Doc 8: Topic 10 (Auto: Vaccine; Descriptive: Vaccine – Virosomes), Prob: 1.00000000
Doc 9: Topic 3 (Auto: Hemocyanin; Descriptive: Hemocyanin), Prob: 1.00000000
Doc 10: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 11: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 12: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 13: Topic 15 (Auto: Vaccines; Descriptive: Vaccines – Adjuvant), Prob: 1.00000000
Doc 14: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 15: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 16: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 17: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 18: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 19: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 20: Topic 4 (Auto: Influenza; Descriptive: Influenza – Freund), Prob: 0.95327842
Doc 21: Topic 4 (Auto: Influenza; Descriptive: Influenza – Freund), Prob: 0.75453431
Doc 22: Topic 5 (Auto: Fluad; Descriptive: Fluad), Prob: 0.44439673
Doc 23: Topic 15 (Auto: Vaccines; Descriptive: Vaccines – Adjuvant), Prob: 1.00000000
Doc 24: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 25: Topic 14 (Auto: Vaccine; Descriptive: Vaccine – Influenza – T14), Prob: 0.93197931
Doc 26: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 27: Topic 5 (Auto: Fluad; Descriptive: Fluad), Prob: 0.40657874
Doc 28: Topic 5 (Auto: Fluad; Descriptive: Fluad), Prob: 0.48981076
Doc 29: Topic 7 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 0.45648676
Doc 30: Topic 14 (Auto: Vaccine; Descriptive: Vaccine – Influenza – T14), Prob: 0.63502802
Doc 31: Topic 4 (Auto: Influenza; Descriptive: Influenza – Freund), Prob: 0.49551954
Doc 32: Topic 13 (Auto: Vaccine; Descriptive: Vaccine – Narcolepsy), Prob: 1.00000000
Doc 33: Topic 13 (Auto: Vaccine; Descriptive: Vaccine – Narcolepsy), Prob: 1.00000000
Doc 34: Topic 13 (Auto: Vaccine; Descriptive: Vaccine – Narcolepsy), Prob: 0.62078454
Doc 35: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 36: Topic 11 (Auto: Hepatitis; Descriptive: Hepatitis), Prob: 0.45018883
Doc 37: Topic 15 (Auto: Vaccines; Descriptive: Vaccines – Adjuvant), Prob: 0.85931664
Doc 38: Topic 3 (Auto: Hemocyanin; Descriptive: Hemocyanin), Prob: 1.00000000
Doc 39: Topic 15 (Auto: Vaccines; Descriptive: Vaccines – Adjuvant), Prob: 0.95391013
Doc 40: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 0.92956315
Doc 41: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 0.72403131
Doc 42: Topic 11 (Auto: Hepatitis; Descriptive: Hepatitis), Prob: 0.50046230
Doc 43: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 44: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Cpg), Prob: 1.00000000
Doc 45: Topic 8 (Auto: Malaria; Descriptive: Malaria – Vaccines), Prob: 0.25840159
Doc 46: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Cpg), Prob: 0.97677377
Doc 47: Topic 9 (Auto: Vaccine; Descriptive: Vaccine – Influenza), Prob: 1.00000000
Doc 48: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 49: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Adjuvants), Prob: 0.81721797
Doc 50: Topic 13 (Auto: Vaccine; Descriptive: Vaccine – Narcolepsy), Prob: 0.71341711
Doc 51: Topic 10 (Auto: Vaccine; Descriptive: Vaccine – Virosomes), Prob: 1.00000000
Doc 52: Topic 9 (Auto: Vaccine; Descriptive: Vaccine – Influenza), Prob: 1.00000000
Doc 53: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 54: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 55: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 56: Topic 16 (Auto: Dmlt; Descriptive: Dmlt), Prob: 1.00000000
Doc 57: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 58: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Adjuvants), Prob: 1.00000000
Doc 59: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Adjuvants), Prob: 0.70090730
Doc 60: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 61: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 62: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 63: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 0.76486099
Doc 64: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Adjuvants), Prob: 1.00000000
Doc 65: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 66: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 0.88825741
Doc 67: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 68: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 69: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 1.00000000
Doc 70: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 1.00000000
Doc 71: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.84067477
Doc 72: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 73: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.61337997
Doc 74: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 0.94126379
Doc 75: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 76: Topic 2 (Auto: Antigens; Descriptive: Antigens), Prob: 0.80509159
Doc 77: Topic 4 (Auto: Influenza; Descriptive: Influenza – Freund), Prob: 0.66443700
Doc 78: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 79: Topic 4 (Auto: Influenza; Descriptive: Influenza – Freund), Prob: 0.58200998
Doc 80: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 1.00000000
Doc 81: Topic 8 (Auto: Malaria; Descriptive: Malaria – Vaccines), Prob: 1.00000000
Doc 82: Topic 4 (Auto: Influenza; Descriptive: Influenza – Freund), Prob: 0.38207391
Doc 83: Topic 5 (Auto: Fluad; Descriptive: Fluad), Prob: 0.95566170
Doc 84: Topic 7 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 0.89121070
Doc 85: Topic 7 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 1.00000000
Doc 86: Topic 8 (Auto: Malaria; Descriptive: Malaria – Vaccines), Prob: 1.00000000
Doc 87: Topic 7 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 0.52914088
Doc 88: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Adjuvants), Prob: 1.00000000
Doc 89: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 90: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.57716516
Doc 91: Topic 14 (Auto: Vaccine; Descriptive: Vaccine – Influenza – T14), Prob: 1.00000000
Doc 92: Topic 5 (Auto: Fluad; Descriptive: Fluad), Prob: 1.00000000
Doc 93: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 94: Topic 4 (Auto: Influenza; Descriptive: Influenza – Freund), Prob: 0.94832540
Doc 95: Topic 5 (Auto: Fluad; Descriptive: Fluad), Prob: 1.00000000
Doc 96: Topic 5 (Auto: Fluad; Descriptive: Fluad), Prob: 0.86559467
Doc 97: Topic 7 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 1.00000000
Doc 98: Topic 14 (Auto: Vaccine; Descriptive: Vaccine – Influenza – T14), Prob: 1.00000000
Doc 99: Topic 7 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 0.93021447
Doc 100: Topic 7 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 0.52914088
Doc 101: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 102: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.88005970
Doc 103: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 104: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.87084129
Doc 105: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.64020298
Doc 106: Topic 3 (Auto: Hemocyanin; Descriptive: Hemocyanin), Prob: 1.00000000
Doc 107: Topic 3 (Auto: Hemocyanin; Descriptive: Hemocyanin), Prob: 1.00000000
Doc 108: Topic 3 (Auto: Hemocyanin; Descriptive: Hemocyanin), Prob: 1.00000000
Doc 109: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.60240989
Doc 110: Topic 3 (Auto: Hemocyanin; Descriptive: Hemocyanin), Prob: 1.00000000
Doc 111: Topic 11 (Auto: Hepatitis; Descriptive: Hepatitis), Prob: 1.00000000
Doc 112: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 113: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 114: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.51469512
Doc 115: Topic 3 (Auto: Hemocyanin; Descriptive: Hemocyanin), Prob: 0.67908285
Doc 116: Topic 10 (Auto: Vaccine; Descriptive: Vaccine – Virosomes), Prob: 0.48706726
Doc 117: Topic 3 (Auto: Hemocyanin; Descriptive: Hemocyanin), Prob: 1.00000000
Doc 118: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Cpg), Prob: 0.96431969
Doc 119: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.51802879
Doc 120: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.97149871
Doc 121: Topic 8 (Auto: Malaria; Descriptive: Malaria – Vaccines), Prob: 0.66528268
Doc 122: Topic 8 (Auto: Malaria; Descriptive: Malaria – Vaccines), Prob: 0.25840159
Doc 123: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 124: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Cpg), Prob: 0.83074852
Doc 125: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Cpg), Prob: 1.00000000
Doc 126: Topic 11 (Auto: Hepatitis; Descriptive: Hepatitis), Prob: 1.00000000
Doc 127: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.87084129
Doc 128: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.59492965
Doc 129: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 130: Topic 17 (Auto: Vaccine; Descriptive: Vaccine – Immune), Prob: 1.00000000
Doc 131: Topic 17 (Auto: Vaccine; Descriptive: Vaccine – Immune), Prob: 1.00000000
Doc 132: Topic 17 (Auto: Vaccine; Descriptive: Vaccine – Immune), Prob: 1.00000000
Doc 133: Topic 3 (Auto: Hemocyanin; Descriptive: Hemocyanin), Prob: 1.00000000
Doc 134: Topic 11 (Auto: Hepatitis; Descriptive: Hepatitis), Prob: 1.00000000
Doc 135: Topic 8 (Auto: Malaria; Descriptive: Malaria – Vaccines), Prob: 0.88928135
Doc 136: Topic 3 (Auto: Hemocyanin; Descriptive: Hemocyanin), Prob: 1.00000000
Doc 137: Topic 18 (Auto: Vaccines; Descriptive: Vaccines – Iscom), Prob: 1.00000000
Doc 138: Topic 18 (Auto: Vaccines; Descriptive: Vaccines – Iscom), Prob: 1.00000000
Doc 139: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.84067477
Doc 140: Topic 18 (Auto: Vaccines; Descriptive: Vaccines – Iscom), Prob: 1.00000000
Doc 141: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 0.90367050
Doc 142: Topic 19 (Auto: Malaria; Descriptive: Malaria – Vaccine), Prob: 1.00000000
Doc 143: Topic 19 (Auto: Malaria; Descriptive: Malaria – Vaccine), Prob: 1.00000000
Doc 144: Topic 19 (Auto: Malaria; Descriptive: Malaria – Vaccine), Prob: 1.00000000
Doc 145: Topic 3 (Auto: Hemocyanin; Descriptive: Hemocyanin), Prob: 1.00000000
Doc 146: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.66102455
Doc 147: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 148: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 149: Topic 10 (Auto: Vaccine; Descriptive: Vaccine – Virosomes), Prob: 0.81363296
Doc 150: Topic 10 (Auto: Vaccine; Descriptive: Vaccine – Virosomes), Prob: 1.00000000
Doc 151: Topic 9 (Auto: Vaccine; Descriptive: Vaccine – Influenza), Prob: 0.63454023
Doc 152: Topic 9 (Auto: Vaccine; Descriptive: Vaccine – Influenza), Prob: 0.64792824
Doc 153: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 154: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Adjuvants), Prob: 0.68935042
Doc 155: Topic 9 (Auto: Vaccine; Descriptive: Vaccine – Influenza), Prob: 0.44840022
Doc 156: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 157: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 158: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.59528557
Doc 159: Topic 1 (Auto: Vaccine; Descriptive: Vaccine – Immunol), Prob: 0.51539581
Doc 160: Topic 16 (Auto: Dmlt; Descriptive: Dmlt), Prob: 1.00000000
Doc 161: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 162: Topic 16 (Auto: Dmlt; Descriptive: Dmlt), Prob: 1.00000000
Doc 163: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Adjuvants), Prob: 1.00000000
